Apple said to put chip veteran Millet in charge of glucose-tracking project
LeoPatrizi/iStock Unreleased via Getty Images
Apple (NASDAQ:AAPL) is reportedly moving a senior chip executive to lead its secretive project aimed at non-invasive blood-sugar tracking, via the company's high-tech Apple Watch.
The project was left without a dedicated leader after the death of scientist Bill Athas at the end of last year, but now Tim Millet, Apple's VP of platform architecture, will take it over, Bloomberg reported.
The 19-year veteran has been a top lieutenant to Apple's hardware-technologies chief Johny Srouji, who this year has been overseeing Athas' former deputies in keeping the work on track.
The glucose-tracking project is making progress even as the Apple Watch has been adding more health sensors in the past couple of years. Apple's blood-sugar tracking isn't ready to fit in the Watch just yet but has been miniaturizing rapidly.
Meantime, Millet has been key to Apple's (AAPL) transition to its own M1 and M2 processors from a previous reliance on Intel.

More on Apple

Apple Stock Is Finally Heading To Where I Think It Belongs
Apple: Upgrading To Hold, We're Now Less Negative
Apple: The iPhone 15 Changes Things, But Is It Enough? (Rating Upgrade)
There Is Only One Apple
French regulator orders Apple to withdraw iPhone 12 model due to high radiation levels
Apple's 'Wonderlust' event draws mixed reviews
Apple's new products -- photos
Seeking Alphaâs Quant Rating on Apple
Historical earnings data for Apple
Dividend scorecard for Apple
Financial information for Apple